Innovative cancer treatments delivering targeted chemotherapy directly to affected areas for enhanced effectiveness and better outcomes.
Minimally invasive and targeted cancer therapies like HIPEC, PIPAC, and HITOC are revolutionizing cancer treatment by delivering chemotherapy directly to affected areas, improving effectiveness while reducing side effects.
HIPEC is a specialized treatment used after Cytoreductive Surgery (CRS) to target cancer cells in the abdominal cavity.
After removing visible tumors, a heated chemotherapy solution is circulated in the abdomen for about 60–90 minutes to destroy microscopic cancer cells.
Used for peritoneal carcinomatosis, colorectal cancer, ovarian cancer, and appendiceal cancer. ✔ Improves survival rates ✔ Minimizes systemic chemotherapy side effects
HITOC is a procedure similar to HIPEC but targets thoracic (chest) cancers such as mesothelioma or pleural metastases.
After surgically removing tumors from the pleural cavity (lining of the lungs), a heated chemotherapy solution is circulated to kill residual cancer cells. ✔ Effective for pleural-based cancers ✔ Improves local tumor control
Symptoms Indicating Need for Treatment
Persistent abdominal or chest pain
Swelling or bloating (ascites) due to fluid buildup
Unexplained weight loss and fatigue
Digestive issues like nausea, vomiting, or loss of appetite
Breathing difficulties (in thoracic cancers)
These advanced therapies offer better outcomes and improved quality of life for patients with advanced cancers in the abdomen and thoracic cavity.
Your experience on this site will be improved by allowing cookies
Cookie Policy